Shkreli Cites Rehab Too Late To Delay FTC Antitrust Trial
By Bryan Koenig (October 19, 2021, 7:35 PM EDT) -- A New York federal judge on Tuesday refused to delay the Federal Trade Commission's antitrust trial against Martin Shkreli, finding that the incarcerated former pharmaceutical executive tried too late to use his participation in a prison drug rehabilitation program to push the proceedings back from mid-December to May.
Shkreli must instead go to trial on Dec. 14 over the FTC's claims that he and his company Vyera Pharmaceuticals monopolized the market for a lifesaving parasitic drug. U.S. District Judge Denise L. Cote rejected the delay motion as "untimely" because Shkreli didn't file it until Oct. 13, just one week before pretrial...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!